Samara State Medical University — Samara

Public research footprint of Samara State Medical University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed or Refractory Multiple Myeloma · Hemophilia B · Symptomatic Carotid Artery Stenosis · Community-acquired Pneumonia

Recently updated registry entries

NCT07742215 — A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients… (Recruiting)
NCT05269004 — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients… (Active Not Recruiting)
NCT01947907 — Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Samara State Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.